ZA201503128B - Bremelanotide therapy for female sexual dysfunction - Google Patents
Bremelanotide therapy for female sexual dysfunctionInfo
- Publication number
- ZA201503128B ZA201503128B ZA2015/03128A ZA201503128A ZA201503128B ZA 201503128 B ZA201503128 B ZA 201503128B ZA 2015/03128 A ZA2015/03128 A ZA 2015/03128A ZA 201503128 A ZA201503128 A ZA 201503128A ZA 201503128 B ZA201503128 B ZA 201503128B
- Authority
- ZA
- South Africa
- Prior art keywords
- bremelanotide
- therapy
- sexual dysfunction
- female sexual
- female
- Prior art date
Links
- 206010057671 Female sexual dysfunction Diseases 0.000 title 1
- FFHBJDQSGDNCIV-MFVUMRCOSA-N bremelanotide Chemical compound C([C@@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCNC(=O)C[C@@H](C(N[C@@H](CC=2NC=NC=2)C(=O)N1)=O)NC(=O)[C@@H](NC(C)=O)CCCC)C(O)=O)C1=CC=CC=C1 FFHBJDQSGDNCIV-MFVUMRCOSA-N 0.000 title 1
- 229950000740 bremelanotide Drugs 0.000 title 1
- 108010072543 bremelanotide Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261722511P | 2012-11-05 | 2012-11-05 | |
| US201361770535P | 2013-02-28 | 2013-02-28 | |
| PCT/US2013/068386 WO2014071339A2 (en) | 2012-11-05 | 2013-11-05 | Uses of bremelanotide in therapy for female sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201503128B true ZA201503128B (en) | 2016-11-30 |
Family
ID=50628268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2015/03128A ZA201503128B (en) | 2012-11-05 | 2015-05-07 | Bremelanotide therapy for female sexual dysfunction |
Country Status (23)
| Country | Link |
|---|---|
| US (7) | US9352013B2 (enExample) |
| EP (1) | EP2916856B2 (enExample) |
| JP (1) | JP6567971B2 (enExample) |
| KR (1) | KR102253526B1 (enExample) |
| CN (2) | CN117860866A (enExample) |
| AU (1) | AU2013337341B2 (enExample) |
| BR (1) | BR112015009936A8 (enExample) |
| DK (1) | DK2916856T4 (enExample) |
| EA (1) | EA032959B9 (enExample) |
| ES (1) | ES2701444T5 (enExample) |
| FI (1) | FI2916856T4 (enExample) |
| GE (1) | GEP20196947B (enExample) |
| HK (1) | HK1211227A1 (enExample) |
| IL (1) | IL238276B (enExample) |
| MX (1) | MX362610B (enExample) |
| MY (1) | MY179755A (enExample) |
| NZ (1) | NZ707246A (enExample) |
| PH (1) | PH12015500915A1 (enExample) |
| PL (1) | PL2916856T5 (enExample) |
| SG (1) | SG11201502949QA (enExample) |
| UA (1) | UA118656C2 (enExample) |
| WO (1) | WO2014071339A2 (enExample) |
| ZA (1) | ZA201503128B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12171807B2 (en) | 2020-01-21 | 2024-12-24 | Cosette Pharmaceuticals, Inc. | Use of bremelanotide in patients with controlled hypertension |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| US7235625B2 (en) * | 1999-06-29 | 2007-06-26 | Palatin Technologies, Inc. | Multiple agent therapy for sexual dysfunction |
| WO2003006620A2 (en) | 2001-07-11 | 2003-01-23 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptides |
| US6579968B1 (en) * | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
| US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
| DE60112440T2 (de) * | 2000-05-31 | 2006-04-20 | Novo Nordisk A/S | Wegwerfbare zweispitzige injektionsnadel |
| MX2007006973A (es) * | 2004-12-09 | 2007-08-15 | West Pharm Serv Inc | Acoplamiento para un dispositivo de auto-inyeccion. |
| WO2009151714A2 (en) * | 2008-03-24 | 2009-12-17 | Palatin Technologies, Inc. | Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions |
| CA2727317C (en) * | 2008-06-09 | 2015-02-17 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| EP2501225B1 (en) * | 2009-11-16 | 2017-11-01 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of melanocortin receptor ligands |
| AU2011242602B2 (en) * | 2010-04-21 | 2015-06-18 | Abbvie Biotechnology Ltd | Wearable automatic injection device for controlled delivery of therapeutic agents |
-
2013
- 2013-11-05 ES ES13851014T patent/ES2701444T5/es active Active
- 2013-11-05 EA EA201590760A patent/EA032959B9/ru not_active IP Right Cessation
- 2013-11-05 PL PL13851014.4T patent/PL2916856T5/pl unknown
- 2013-11-05 HK HK15112118.5A patent/HK1211227A1/xx unknown
- 2013-11-05 SG SG11201502949QA patent/SG11201502949QA/en unknown
- 2013-11-05 WO PCT/US2013/068386 patent/WO2014071339A2/en not_active Ceased
- 2013-11-05 KR KR1020157014777A patent/KR102253526B1/ko active Active
- 2013-11-05 MY MYPI2015001016A patent/MY179755A/en unknown
- 2013-11-05 CN CN202410025611.5A patent/CN117860866A/zh active Pending
- 2013-11-05 FI FIEP13851014.4T patent/FI2916856T4/fi active
- 2013-11-05 CN CN201380056487.9A patent/CN104755094A/zh active Pending
- 2013-11-05 MX MX2015005486A patent/MX362610B/es active IP Right Grant
- 2013-11-05 GE GEAP201313826A patent/GEP20196947B/en unknown
- 2013-11-05 DK DK13851014.4T patent/DK2916856T4/da active
- 2013-11-05 BR BR112015009936A patent/BR112015009936A8/pt not_active Application Discontinuation
- 2013-11-05 UA UAA201503523A patent/UA118656C2/uk unknown
- 2013-11-05 NZ NZ707246A patent/NZ707246A/en unknown
- 2013-11-05 EP EP13851014.4A patent/EP2916856B2/en active Active
- 2013-11-05 JP JP2015540853A patent/JP6567971B2/ja active Active
- 2013-11-05 AU AU2013337341A patent/AU2013337341B2/en active Active
-
2014
- 2014-06-24 US US14/313,258 patent/US9352013B2/en active Active
-
2015
- 2015-04-14 IL IL238276A patent/IL238276B/en active IP Right Grant
- 2015-04-23 PH PH12015500915A patent/PH12015500915A1/en unknown
- 2015-05-05 US US14/704,223 patent/US9700592B2/en active Active
- 2015-05-07 ZA ZA2015/03128A patent/ZA201503128B/en unknown
-
2017
- 2017-07-06 US US15/642,772 patent/US10286034B2/en active Active
-
2019
- 2019-03-28 US US16/368,417 patent/US20190216888A1/en not_active Abandoned
-
2020
- 2020-10-27 US US17/081,732 patent/US20210060120A1/en not_active Abandoned
-
2022
- 2022-07-14 US US17/864,486 patent/US20220362328A1/en not_active Abandoned
-
2024
- 2024-06-13 US US18/742,358 patent/US20240335502A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12171807B2 (en) | 2020-01-21 | 2024-12-24 | Cosette Pharmaceuticals, Inc. | Use of bremelanotide in patients with controlled hypertension |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2512765B (en) | Devices and methods for promoting female sexual wellness | |
| LT2726048T (lt) | Seksualinės stimuliacijos įrenginys | |
| PT2964315T (pt) | Sistema para tratamento de disfunção neuromotora | |
| GB201006495D0 (en) | Sexual stimulator | |
| AU338103S (en) | Therapeutic device for stimulating muscle contractions | |
| GB201119608D0 (en) | Stimulation apparatus | |
| EP2777680A4 (en) | DEVICE FOR FEMALE SEXUAL STIMULATION | |
| PL2807170T3 (pl) | Limonoidy fragmaliny do leczenia dysfunkcji seksualnych | |
| PL2974728T3 (pl) | Środek terapeutyczny na dysfunkcję gruczołu Meiboma | |
| ZA201502595B (en) | Therapeutic methods | |
| EP2777679A4 (en) | DEVICE FOR MALE SEXUAL STIMULATION | |
| EP2910234A4 (en) | HYDRAULIC MASSAGE DEVICE | |
| PL2827743T3 (pl) | Element z zębami | |
| GB201113000D0 (en) | Stimulation device | |
| EP2734158A4 (en) | STIMULATING DEVICE | |
| ZA201308176B (en) | Therapeutic treatment | |
| ZA201503128B (en) | Bremelanotide therapy for female sexual dysfunction | |
| HK40108156A (zh) | 用於女性性功能障碍的布雷默浪丹疗法 | |
| IL237107B (en) | Use of adenosine a3 receptor ligands in the treatment of sexual disorders | |
| TWM475277U (en) | Sexual massage cup | |
| PL2720533T3 (pl) | Urządzenie stymulujące | |
| HUE050066T2 (hu) | Meibom-mirigy rendellenességek kezelésére szolgáló gyógyszerészeti szer | |
| GB201317518D0 (en) | Versatile sexual stimulation devices | |
| GB201217173D0 (en) | Therapeutic method | |
| SG2013090550A (en) | Muscle stimulation system |